Average Co-Inventor Count = 7.88
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (9 from 3,681 patents)
2. Bristol-myers Squibb Pharma Company (2 from 234 patents)
3. Viiv Healthcare UK (no. 4) Limited (1 from 8 patents)
4. Bristol-myers Squibb Holdings Ireland (0 patent)
12 patents:
1. 11369624 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents
2. 9006455 - Hepatitis C virus inhibitors
3. 8871771 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents
4. 8461333 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents
5. 8168615 - Prodrugs of piperazine and substituted piperidine antiviral agents
6. 7968718 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
7. 7745625 - Prodrugs of piperazine and substituted piperidine antiviral agents
8. 7728027 - Process for synthesizing compounds useful for treating hepatitis C
9. 7601715 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
10. 7442792 - Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
11. 7208596 - Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
12. 6162913 - Preparation of